Lawsuits

Bernstein Liebhard LLP reports on a February 15, 2012 article published in the New York Times revealing that Johnson & Johnson (“J&J”) continued to sell one model of its DePuy ASR hip replacement implants abroad after the U.S. Food and Drug Administration (“FDA”) rejected J&J’s...

On February 8, 2012, research presented at the 2012 Annual Meeting of the American Academy of Orthopaedic Surgeons (“AAOS”) concluded that patients who suffer a Fosamax thigh fracture while taking bisphosphonates such as Fosamax, Boniva, Reclast and Actonel can decrease their risk of suffering f...

Bernstein Liebhard LLP is pleased to announce the launch of a new video that provides useful information for individuals who were affected by the DePuy ASR hip recall. The video can be found on the Firm’s website, as well as on YouTube. In August 2010, DePuy Orthopaedics, a subsidiary of Johnson &...

On February 4, 2012, The Sunday Telegraph reported that metal-on-metal hip implants may be linked to cancer. According to The Telegraph, next month researchers from the University of Bristol will present their findings at the British Hip Society conference. Researchers participating in the study con...

Recently, the U.S. Food and Drug Administration (“FDA”) has been repeatedly criticized by the media, experts and congressmen for its medical device approval process. Calls for regulatory reform have been become commonplace given the wave of medical devices approved by the FDA that have since pro...

PRESS RELEASE: Bernstein Liebhard LLP reports that on February 3, 2012, the U.S. Judicial Panel on Multidistrict Litigation (“JPML”) ordered that all Fosamax lawsuits filed in federal court by individuals alleging that they sustained an atypical femur fracture as a result of taking the bispho...

PRESS RELEASE: Bernstein Liebhard LLP reports that on February 7, 2012, the U.S. Judicial Panel on Multidistrict Litigation ordered that three separate pelvic mesh MDLs be consolidated before one judge given that each group of lawsuits, which involve various models of surgical mesh manufactured b...

PRESS RELEASE: Bernstein Liebhard LLP reports that on January 31, 2012, Democratic Representative Edward Markey of Massachusetts introduced a bill (HR3847) that would block medical devices from utilizing the 510(k) process in order to receive market approval by the U.S. Food and Drug Administrati...

PRESS RELEASE: Bernstein Liebhard LLP reports that on January 20, 2012, Representative Henry Waxman of California led House Democrats from the Energy and Commerce Committee in writing a letter to several chairmen, requesting that the Committee hold hearings to review the safety of medical devices...

On January 20, 2012, Representative Henry Waxman of California led House Democrats from the Energy and Commerce Committee in writing a letter to several chairmen, requesting that the Committee hold hearings to review the safety of medical devices implanted into patients as well as request documents ...